Armstrong Advisory Group »

Cue Biopharma shares owned by Armstrong Advisory Group

Quarter-by-quarter ownership of Cue Biopharma (CUE) shares owned by Armstrong Advisory Group from 13F filings

Historical chart of Armstrong Advisory Group investment in Cue Biopharma

Tip: Access up to 7 years of quarterly data

All positions including Cue Biopharma held by Armstrong Advisory Group consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Cue Biopharma by Armstrong Advisory Group

Quarter filed Position value Share count Share price at filing
2024-03-31 $317 120 2.64
2023-12-31 $317 120 2.64
2023-09-30 $276 120 2.30
2023-06-30 $438 120 3.65
2023-03-31 $429 120 3.58
2022-12-31 $342 120 2.85

More positions owned by Armstrong Advisory Group

Ishares Tr 7-10 Yr Trsy Bd (IEF)
Vanguard World Fds Inf Tech Etf (VGT)
Spdr Ser Tr Portfolio S&p500 (SPLG)
Schwab Strategic Tr 1000 Index Etf (SCHK)
Vanguard Bd Index Fds Total Bnd Mrkt (BND)
Vanguard World Fds Health Car Etf (VHT)
Select Sector Spdr Tr Financial (XLF)
Ishares Tr Core S&p500 Etf (IVV)
Select Sector Spdr Tr Sbi Cons Discr (XLY)
Ishares Tr Us Treas Bd Etf (GOVT)
Ishares Tr 3 7 Yr Treas Bd (IEI)
Vanguard World Fds Comm Srvc Etf (VOX)
Vanguard Index Fds Extend Mkt Etf (VXF)
Select Sector Spdr Tr Indl (XLI)
Select Sector Spdr Tr Sbi Cons Stpls (XLP)

View all positions for Armstrong Advisory Group

Top funds holding Cue Biopharma

Vanguard Group
BlackRock
Bleichroeder
Geode Capital Management
Robertson Stephens Wealth Management
Dimensional Fund Advisors
Northern Trust
Millennium Management
Monaco Asset Management SAM
Sigma Planning
Bank of America Corporation
GSA Capital Partners
Stifel Financial
Citadel Advisors
Morgan Stanley

View all funds holding Cue Biopharma